Chip Davis, president and CEO of the Generic Pharmaceutical Association (GPhA) offered praise of a study published on May 9, 2016 in the Journal of the American Medical Association ( JAMA ) Internal Medicine . The new study revealed that from 2010 2012, in the United States, moOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.